Consequently, the success of prodrug strategies are very powerful means to improve formulation and delivery properties of drugs. However, prodrug intervention must be an integral part of the drug ...

In April 2025, Vir Biotechnology Inc. announced a phase 1b/2 platform study framework to evaluate the safety and efficacy of ...

Lisdexamfetamine dimesylate (Vyvanse; New River Pharmaceuticals/Shire), a prodrug of D-amphetamine ... this results in a need for in-school administration, which has the potential for ...

The company’s lead drug candidate, MIV-818, is a liver cancer targeted prodrug that Medivir is ... Medicines Agency and the US Food and Drug Administration and reaching cancer patients more ...

In March 2025, AbViro LLC announced a phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare ...